EFFECT OF CHLOROPHYLLIN, AN SEMI-SYNTHETIC CHLOROPHYLL MOLECULE ON HYPERGLYCEMIA AND HYPERLIPIDEMIA IN STREPTOZOTOCIN INDUCED DIABETIC MICE
Keywords:
Chlorophyllin, Diabetes mellitus, StreptozotocinAbstract
Objective: The aim of the present study was to determine the effect of chlorophyllin (CHL) on hyperglycemia and hyperlipidemia in streptozotocin (STZ) induced diabetic mice.
Methods: Diabetes was induced in mice by administering 150 mg/kg body weight (bw) dose of STZ. The effect of 10, 25, 50 and 100 mg/kg bw doses of CHL on hyperglycemia was examined in diabetic mice for the acute and sub-acute period. The intraperitoneal glucose tolerance test (IPGTT) was performed in diabetic (Group A) as well as diabetic treated with CHL (Group B), metformin (Group C), glibenclamide (Group D), and insulin (Group E) groups. The percent glycosylated hemoglobin (GHb%) level, lipid profile, and atherogenic index (AI) were determined in normal (Group A), diabetic (Group B) as well as diabetic treated with CHL (Group C), and metformin (Group D) groups.
Results: In both acute and sub-acute antihyperglycemic study, 50 mg/kg bw dose of CHL was found effective in reduction of blood glucose level significantly and considered as an optimum dose. In IPGTT, the significant reduction of blood glucose level in Group B was observed at 2 h (h) and 4 h in comparison with Group A. The GHb%, lipid profile and AI value of Group C were found significantly different from Group B in the study.
Conclusion: The present study justifies the antihyperglycemic and antihyperlipidemic effects of CHL in STZ induced diabetic mice, hence suggesting its beneficial effect in the treatment of diabetes.Â
Downloads
References
IDF Diabetes atlas. 7th edition. International Diabetes Federation; 2015. p. 49-51.
World Health Organization; 1999. Available from: http://www.who.int/iris/bitstream/10665/66040/1/WHO_NCD_NCS_99.2.pdf. [Last accessed on 20 Feb 2016].
Kumar PJ, Clark M. Diabetes mellitus and other disorders of metabolism. In: Textbook of Clinical Medicine. London, Saunders Publication Ltd; 2002. p. 1069-121.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 Suppl 1:62-9.
Dabelea D, Hanson RL, Bennett PH, Roumain J, Knowler WC, Pettitt DJ. Increasing prevalence of type II diabetes in American Indian children. Diabetologia 1998;41:904-10.
Kamat JP, Boloor KK, Devasagayam TPA. Chlorophyllin as an effective antioxidant against membrane damage in vitro and ex vivo. Bochim Biophys Acta 2000;1487:113-27.
Kumar SS, Devasagayam TP, Bhushan B, Verma NC. Scavenging of reactive oxygen species by chlorophyllin: an ESR study. Free Radical Res 2001;35:563-74.
Kumar SS, Shankar B, Sainis KB. Effect of chlorophyllin against oxidative stress in splenic lymphocytes in vitro and in vivo. Biochim Biophys Acta 2004;1672:100-11.
Lanfer-Marquez UM, Barros RMC, Sinnecker P. Antioxidant activity of chlorophylls and their derivatives. Food Res Int 2005;38:885-91.
Bhandari U, Kanojia R, Pillai KK. Effect of ethanolic extract of Zingiber officinale on dyslipidemia in diabetic rats. J Ethnopharmacol 2005;97:227-30.
Syiem D, Khup PZ. Evaluation of Flemingia macrophylla L., a traditionally used plant of the north eastern region of India for hypoglycemic and antihyperglycemic effect on mice. Pharmacologyonline 2007;366:355-66.
Trivelli LA, Ranney HM, Lal HT. Hemoglobin components in patients with diabetes mellitus. N Engl J Med 1971;284:353-7.
Gonen B, Rubenstein AH. Hemoglobin A1 and diabetes mellitus. Diabetologia 1978;15:1-8.
Gasting D, Aliyu R, Kuiate JR, Garba IH, Jaryum KH, Tedongmo N, et al. Toxicological evaluation of the aqueous extract of Allium sativum bulbs on laboratory mice and rats. Cameroon J Exp Biol 2005;1:39-45.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
Malaspina JP, Bussiere H, Calve GLe. The total cholesterol/HDL cholesterol ratio: a suitable atherogenesis index. Atherosclerosis 1981;40:373-5.
Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med 1967;126:201-5.
Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 2000;43:1528-33.
Rakieten N, Rakieten ML, Nadkarni MV. Studies on the diabetogenic action of streptozotocin. Cancer Chemother Rep 1963;29:91-8.
Rerup CC. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 1970;22:485-518.
Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine 1995;2:137-89.
Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 1976;295:417-20.
Goldberg IJ. Diabetic dyslipidemia-causes and consequences. J Clin Endocrinol Metab 2001;86:965-71.